A perspective on diuretic resistance in chronic congestive heart failure

Ther Adv Cardiovasc Dis. 2017 Oct;11(10):271-278. doi: 10.1177/1753944717718717. Epub 2017 Jul 20.

Abstract

Chronic congestive heart failure (CHF) is a complex disorder characterized by inability of the heart to keep up the demands on it, followed by the progressive pump failure and fluid accumulation. Although the loop diuretics are widely used in heart failure (HF) patients, both pharmacodynamic and pharmacokinetic alterations are thought to be responsible for diuretic resistance in these patients. Strategies to overcome diuretic resistance include sodium intake restriction, changes in diuretic dose and route of administration and sequential nephron diuretic therapy. In this review, we discuss the definition, prevalence, mechanism of development and management strategies of diuretic resistance in HF patients.

Keywords: cardiorenal syndrome; diuretic resistance; diuretics; heart failure; renal failure.

Publication types

  • Review

MeSH terms

  • Chronic Disease
  • Diuresis / drug effects*
  • Drug Resistance*
  • Heart Failure / diagnosis
  • Heart Failure / drug therapy*
  • Heart Failure / physiopathology
  • Hemodynamics / drug effects*
  • Humans
  • Kidney / drug effects*
  • Kidney / physiopathology
  • Risk Factors
  • Sodium Potassium Chloride Symporter Inhibitors / adverse effects
  • Sodium Potassium Chloride Symporter Inhibitors / pharmacokinetics
  • Sodium Potassium Chloride Symporter Inhibitors / therapeutic use*

Substances

  • Sodium Potassium Chloride Symporter Inhibitors